Explore Every Angle

The Global X HealthTech ETF (HEAL) seeks to provide exposure to companies driving healthcare's technological revolution.

By leveraging advances in genomics and artificial intelligence, companies working to treat cancer can tap into numerous potential growth drivers.

Novel therapeutic agents can differentiate themselves via a host of factors, which may also impact potential revenue opportunities. Charting Disruption.

Drug development is key to pharmaceutical industry success, and it’s crucial for investors to understand a drug’s lifecycle to navigate this dynamic sector.

GLP-1s have already seen enormous success treating obesity and diabetes, and their achievements could be replicated in other illnesses.